Invest in IPO
(initial public offering)

Unique investment before the start of trading
Invest in IPO
BIVI BIOVIE INC 23.01.2020 Invest in IPO
BMEZ BlackRock Health Sciences Trust II 28.01.2020 Invest in IPO
ANVS Annovis Bio 29.01.2020 Invest in IPO
ANPC AnPac Bio-Medical Science 29.01.2020 Invest in IPO
FLRZ F5 Finishes, Inc 30.01.2020 Invest in IPO
Contact usCollapse

How to invest in IPO

Find IPO
Our calendar contains the latest and most relevant information on initial public offerings.
Open MT5 Global account
Thousands of instruments for investing and trading.
Transfer funds to a trading account
Instant deposit and withdrawal in many convenient ways.
Apply for IPO in the Private Office or MT5 Global trading platform
Preliminary position will immediately appear in the portfolio.

IPO Calendar

BIVI
BIOVIE INC
Follow-on
Date
23.01.2020
Price range, $
Expected

BioVie Inc. (OTCQB: BIVI; up-listing to NASDAQ) Approximately $15,000,000 of units, with each unit consisting of one share of Class A common stock and one-half (1/2) of one warrant, each whole warrant exercisable for one share of common stock. After giving effect to the planned 1:125 reverse stock split. The final public offering price will be determined through negotiation between us and the lead underwriters in the offering and the recent market price used throughout this prospectus may not be indicative of the final offering price

BMEZ
BlackRock Health Sciences Trust II
IPO
Date
28.01.2020
Price range, $
$20 - $20

BlackRock Health Sciences Trust II is a newly-organized, non-diversified, closed-end management investment company with no operating history. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation.

ANVS
Annovis Bio
IPO
Date
29.01.2020
Price range, $
$6 - $8

Annovis is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD).

ANPC
AnPac Bio-Medical Science
IPO
Date
29.01.2020
Price range, $
$12 - $14

We are a biotechnology company focusing on early cancer screening and detection. We market and sell a multi-cancer screening and detection test that uses our innovative, patented cancer differentiation analysis, or CDA, technology and our proprietary cancer-detection device, or CDA device.

FLRZ
F5 Finishes, Inc
IPO
Date
30.01.2020
Price range, $
$9 - $11

We are a provider of commercial flooring solutions, including sales, installation and maintenance services for existing and new commercial buildings.

ZCMD
Zhongchao Inc.
IPO
Date
31.01.2020
Price range, $
$4 - $4.5

We are a provider of healthcare information, education, and training services to healthcare professionals and the public in China.

YZCM
Leaping Group Co., Ltd.
IPO
Date
04.02.2020
Price range, $
$4 - $6

Multimedia service provider based in Shenyang, China, with business relationships with national advertising clients.

MITQ
Moving iMage Technologies
IPO
Date
10.02.2020
Price range, $
$4 - $4.5

We are a digital cinema company who designs, manufactures, integrates, installs and distributes a full suite of proprietary and custom designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements.

NRI
Fortis Minerals
IPO
Date
Expected
Price range, $
Expected

We are a returns-focused company formed to pursue oil and natural gas mineral and royalty interest opportunities in leading oil-weighted onshore domestic resource plays.

NCTY
The9 Limited
IPO
Date
Expected
Price range, $
Expected

Our goal is to become a diversified high-tech Internet company targeting fast growing technology sectors primarily in China. Our business segments primarily consist of online games and electric vehicles through our joint venture agreement with Faraday&Future Inc. or F&F.

HZ
HeZhong International (Holding) Ltd
IPO
Date
Expected
Price range, $
$4 - $4

We are a rapidly-growing online peer-to-peer lending marketplace facilitating loans between borrowers and investors, providing borrowers accessible, affordable credit and offering investors attractive risk-adjusted returns. From our inception through June 30, 2018, we have matched loan transactions with an aggregate value of approximately RMB4.99 billion ($743.53 million). We primarily conduct our businesses in Guangdong Province, China and service exclusively Chinese borrowers and investors.

INBX
Inhibrx
IPO
Date
Expected
Price range, $
Expected

We are a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.

KRAT
Karat Packaging
IPO
Date
Expected
Price range, $
$7 - $9

We are a rapidly-growing manufacturer and distributor of environmentally-friendly, single-use disposable products primarily used in restaurants and foodservice settings. We supply a wide range of products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery and straws.

CNTX
Centrexion Therapeutics Corp
IPO
Date
Expected
Price range, $
Expected

We are a late clinical-stage biopharmaceutical company focused on becoming the leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.

BRP
BRP Group
IPO
Date
Expected
Price range, $
Expected

Independent insurance distribution firm.

PGNY
Progyny, Inc
IPO
Date
Expected
Price range, $
Expected

Progyny is a leading benefits management company specializing in fertility and family building benefits solutions in the United States.

DDDD
4D Molecular Therapeutics
IPO
Date
Expected
Price range, $
Expected

We are a development stage precision gene therapy company dedicated to pioneering the development of targeted therapies based on our next-generation AAV vectors.

PHAT
Phathom Pharmaceuticals
IPO
Date
Expected
Price range, $
Expected

We are a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.

CABA
Cabaletta Bio
IPO
Date
Expected
Price range, $
Expected

We are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.

DAO
Youdao
IPO
Date
Expected
Price range, $
Expected

Youdao has developed and used technologies to provide learning content, applications and solutions to users of all ages

BEAM
Beam Therapeutics
IPO
Date
Expected
Price range, $
Expected

We are a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.

TFFP
TFF Pharmaceuticals
IPO
Date
Expected
Price range, $
$5 - $5

We are an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on our patented Thin Film Freezing, or TFF, technology platform.

OYST
Oyster Point Pharma
IPO
Date
Expected
Price range, $
Expected

We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.

CMDS
CloudMinds
IPO
Date
Expected
Price range, $
Expected

We have built and operate an open end-to-end cloud robot system, and offer it as a service to the world.

REPX
Riley Exploration - Permian
IPO
Date
Expected
Price range, $
Expected

We are a growth-oriented, independent oil and natural gas company focused on rapidly growing our reserves, production and cash flow through the acquisition, exploration, development and production of oil, natural gas, and natural gas liquids, or NGLs, reserves in the Permian Basin.

OLB
OLB GROUP
IPO
Date
Expected
Price range, $
Expected

UPLISTING: We are FinTech company and payment facilitator (“PayFac”) that focuses on a suite of products in the merchant services and payment facilitator verticals and provides integrated business solutions to merchants throughout the United States.

AIH
Aesthetic Medical International Holdings Group
IPO
Date
Expected
Price range, $
Expected

Aesthetic medical service company.

HUIZ
Huize Holding Ltd
IPO
Date
Expected
Price range, $
Expected

We are a leading independent online insurance product and service platform in China that is not affiliated with insurance companies or other insurance industry participants.

RAPT
RAPT Therapeutics
IPO
Date
Expected
Price range, $
Expected

We are a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.

VRME
VerifyMe, Inc.
Follow-on
Date
Expected
Price range, $
Expected

FOLLOW-ON OFFERING: Nasdaq uplisting; VerifyMe, Inc. (“VerifyMe,” the “Company,” “we” or “us”) is a developmental stage technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products.

ML
Meili Auto Holdings
IPO
Date
Expected
Price range, $
Expected

We are a pioneer and leader in China’s used car financing market, focusing on facilitating loans from financial institutions to prime borrowers in used car transactions.

REYN
Reynolds Consumer Products
IPO
Date
Expected
Price range, $
Expected

We are a market-leading consumer products company with a presence in 95% of households across the United States.

GTH
Genetron Holdings
IPO
Date
Expected
Price range, $
Expected

We are a leading and fast-growing precision oncology company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment.

UK
Ucommune Group Holdings
IPO
Date
Expected
Price range, $
Expected

We operate the largest co-working space community in China in terms of the number of co-working spaces, aggregate managed area and number of cities covered in China as of September 30, 2019, according to Frost & Sullivan.

AHI
Avadim Health
IPO
Date
Expected
Price range, $
Expected

We are a high-growth, healthcare and wellness company that sells topical products to improve immune health, neuromuscular health and skin barrier health.

NREF
Nexpoint Multifamily Capital Trust
IPO
Date
Expected
Price range, $
Expected

We are a newly formed commercial real estate finance company. Our strategy is to originate, structure and invest in first mortgage loans, mezzanine loans, preferred equity and alternative structured financings in commercial real estate properties, as well as multifamily commercial mortgage backed securities, or CMBS, securitizations, or collectively our target assets.

ONEM
1Life Healthcare
IPO
Date
Expected
Price range, $
Expected

We are a membership-based primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live and click.

BDTX
Black Diamond Therapeutics
IPO
Date
Expected
Price range, $
Expected

We are a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies.

ARQT
Arcutis Biotherapeutics
IPO
Date
Expected
Price range, $
Expected

We are a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs.

DNK
Phoenix Tree Holdings Ltd
IPO
Date
17.01.2020
Price range, $
$14.5 - $16.5

We started Danke in 2015 to provide young people with comfortable yet affordable homes. Today, we are one of the largest co-living platforms in China with the fastest growth, according to iResearch.

IMAB
I-Mab
IPO
Date
17.01.2020
Price range, $
$12 - $15

We are a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

LIZI
LIZHI Inc
IPO
Date
17.01.2020
Price range, $
$11 - $13

Audio technology company.

VEL
Velocity Financial
IPO
Date
17.01.2020
Price range, $
$14 - $16

We are a vertically integrated real estate finance company founded in 2004. We primarily originate and manage investor loans secured by 1-4 unit residential rental and small commercial properties, which we refer to collectively as investor real estate loans.

YCBD
cbdMD, Inc.
Follow-on
Date
10.01.2020
Price range, $
Expected

Level Brands strives to be an innovative licensing, marketing and brand management company with a focus on lifestyle-based products

TPVG
TriplePoint Venture Growth BDC Corp
Overnight
Date
09.01.2020
Price range, $
Expected

TriplePoint Venture Growth BDC Corp. is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended.

MKD
Molecular Data Inc
IPO
Date
30.12.2019
Price range, $
$5 - $7

We are a leading technology-driven platform in China’s chemical industry, connecting participants along the chemical value chain through our integrated solutions

MNPR
Monopar Therapeutics
IPO
Date
19.12.2019
Price range, $
$8 - $10

We are a clinical stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients.

YGYIP
Youngevity International
Follow-on
Date
18.12.2019
Price range, $
Expected

9.75% Series D Cumulative Redeemable Perpetual Preferred Stock

SPT
Sprout Social
IPO
Date
13.12.2019
Price range, $
$16 - $18

Introduced in 2011, our cloud software brings together social messaging, data and workflows in a unified system of record, intelligence and action.